The ADAM10 gene plays a significant role in the susceptibility to Alzheimer's disease type 18, a form of the condition that has a genetic underpinning. This particular gene is involved in the cellular processes that can influence the development of Alzheimer's disease, making its study crucial for understanding individual risks and potential therapeutic targets.
Genetic testing for the ADAM10 gene's involvement in Alzheimer's disease type 18 susceptibility offers a proactive approach for individuals concerned about their risk of developing this neurodegenerative disorder. Conducted at DNA Labs UAE, this specialized test aims to identify specific genetic markers associated with an increased risk of Alzheimer's disease, providing valuable insights into one's genetic predisposition.
The test is priced at 4400 AED, reflecting the comprehensive analysis and personalized assessment it offers. By opting for this test, individuals can gain crucial information on their genetic makeup, empowering them with the knowledge to make informed decisions regarding their health and potential preventive measures against Alzheimer's disease.
The APOE gene Alzheimer's disease type 2 genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify the presence of specific alleles of the APOE gene that are associated with an increased risk of developing Alzheimer's disease. The APOE gene is instrumental in the metabolism of fats in the body and has three common alleles: ε2, ε3, and ε4. The ε4 allele is linked to a higher risk of Alzheimer's disease, while the ε2 allele is considered to provide some protection against the condition.
This test is crucial for individuals with a family history of Alzheimer's disease or those who wish to understand their genetic predisposition to this neurodegenerative disorder. It involves a simple sample collection process, after which the DNA is analyzed to determine the specific APOE alleles present.
The cost of the APOE gene Alzheimer's disease type 2 genetic test at DNA Labs UAE is 4400 AED. This price includes the full testing procedure and a comprehensive report that explains the results and their implications for the individual's risk of developing Alzheimer's disease. It's an invaluable tool for those seeking early intervention strategies or simply peace of mind regarding their genetic health.
The "PSEN1 Gene Alzheimer Disease Type 3 Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the PSEN1 gene, which are linked to an increased risk of developing early-onset Alzheimer's disease, also known as Alzheimer disease type 3. This form of Alzheimer's disease is hereditary and tends to manifest at a younger age, typically before the age of 65. The PSEN1 gene plays a crucial role in the production of a protein that is part of the process that leads to the accumulation of amyloid plaques, a hallmark of Alzheimer's disease.
Conducted at DNA Labs UAE, this genetic test is a vital tool for individuals with a family history of early-onset Alzheimer's disease, providing them with crucial information regarding their genetic predisposition to the condition. By undergoing this test, individuals can make informed decisions about their future health and lifestyle, and in some cases, take preventative measures or plan for early intervention.
The cost of the PSEN1 Gene Alzheimer Disease Type 3 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the testing procedure, analysis, and comprehensive reporting. Given the specialized nature of this test and its significance in potentially altering the course of one's life, the cost reflects the value of advanced genetic insights into one's health.
The PSEN2 Gene Alzheimer's Disease Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PSEN2 gene, which are linked to the development of Alzheimer's disease type 4. This form of Alzheimer's disease is inherited in an autosomal dominant pattern, meaning a mutation in just one copy of the gene in each cell is sufficient to increase an individual's risk of developing the condition. The test is crucial for individuals with a family history of Alzheimer's disease, as it can provide valuable insights into their genetic predisposition to this type of dementia.
The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic variations in the PSEN2 gene that are associated with Alzheimer's disease type 4. The results of this test can help individuals make informed decisions about their health and lifestyle, and in some cases, may lead to the consideration of preventative measures or early interventions.
The cost of the PSEN2 Gene Alzheimer's Disease Type 4 Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and the specific expertise required to conduct and interpret the test, this price reflects the comprehensive service provided, including the genetic counseling that is often recommended to discuss the results and their implications for the individual and their family members.
The SORL1 gene, associated with early-onset Alzheimer's disease, is a focus of genetic testing aimed at identifying individuals at risk of developing this autosomal dominant form of Alzheimer's. This specific form of the disease manifests earlier than the more common late-onset Alzheimer's, often affecting individuals before the age of 65. The SORL1 gene has been identified as a significant player in the disease's pathology, influencing the processing of amyloid precursor protein, which is crucial in the development of amyloid plaques—a hallmark of Alzheimer's disease.
DNA Labs UAE offers a comprehensive genetic test targeting the SORL1 gene to determine an individual's risk of developing early-onset Alzheimer's disease. The test, priced at 4400 AED, involves a detailed analysis of the SORL1 gene to identify mutations that are known to contribute to the development of Alzheimer's disease. This predictive testing is particularly valuable for individuals with a family history of early-onset Alzheimer's, providing them with crucial information regarding their genetic predisposition to the disease.
By opting for this test, individuals can gain insights into their genetic makeup, allowing them to make informed decisions about their health and future. The results can also guide healthcare professionals in tailoring prevention strategies and early intervention plans, potentially mitigating the impact of the disease. DNA Labs UAE ensures confidentiality and accuracy, offering support and guidance throughout the testing process.
The RTN3 gene is associated with the development and progression of Alzheimer's disease, a neurodegenerative disorder characterized by cognitive decline and memory loss. Mutations or alterations in the RTN3 gene have been linked to the disease's pathology, making it a significant target for genetic testing.
DNA Labs UAE offers a specialized genetic test focused on analyzing the RTN3 gene to identify potential risks or the presence of genetic markers associated with Alzheimer's disease. This test is crucial for individuals with a family history of Alzheimer's or those experiencing early symptoms of cognitive decline, as it can provide valuable insights into their genetic predisposition to the disease.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for specific mutations or alterations in the RTN3 gene. The results can help guide personalized prevention strategies, early interventions, or inform patients about their risk levels, potentially leading to more targeted and effective management of the condition.
The cost of the RTN3-related genetic test at DNA Labs UAE is 4400 AED. This investment can be invaluable for individuals seeking to understand their genetic risk for Alzheimer's disease and take proactive steps towards managing their health.
The ST3GAL5 Gene Amish Infantile Epilepsy Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the ST3GAL5 gene, which have been linked to a rare form of epilepsy predominantly found in the Amish community, known as Amish Infantile Epilepsy Syndrome. This condition is characterized by frequent seizures that begin in infancy, along with other potential developmental issues. The test, which costs 4400 AED, involves analyzing the patient's DNA to identify any genetic abnormalities in the ST3GAL5 gene, providing crucial information for accurate diagnosis and tailored treatment plans. This genetic test is pivotal for early intervention and management of the syndrome, offering hope and support to affected families.
The TTR Gene Amyloidosis Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the transthyretin (TTR) gene. These mutations are known to cause transthyretin amyloidosis, a rare condition characterized by the accumulation of abnormal amyloid proteins in the body's tissues and organs. This progressive disease can lead to various health issues, including neuropathy, cardiomyopathy, and gastrointestinal problems.
DNA Labs UAE offers this crucial genetic test for individuals who have symptoms of TTR amyloidosis or have a family history of the condition, providing them with essential information about their genetic status. The test involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the lab for the presence of specific mutations in the TTR gene.
The cost of the TTR Gene Amyloidosis Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the TTR gene. By opting for this test, individuals can gain valuable insights into their genetic predisposition to transthyretin amyloidosis, enabling them to make informed decisions about their health and potential treatment options.
The GSN Gene Amyloidosis Finnish type genetic test is a specialized diagnostic procedure designed to identify mutations in the GSN gene, which are responsible for the development of Finnish type amyloidosis. This rare form of amyloidosis is characterized by the accumulation of abnormal amyloid proteins in various tissues of the body, leading to a wide range of symptoms including kidney problems, nerve damage, and heart issues. The test is particularly relevant for individuals of Finnish descent or those with a family history of the condition, as it can provide crucial information for early diagnosis and management.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. The sample is then analyzed using advanced genetic sequencing techniques to detect any mutations in the GSN gene. The results of this test can help guide treatment decisions and allow for the implementation of preventive measures to manage symptoms and improve the quality of life for affected individuals.
The cost of the GSN Gene Amyloidosis Finnish type genetic test at DNA Labs UAE is 4400 AED. This price reflects the complexity of the genetic analysis and the specialized expertise required to accurately interpret the results. Patients considering this test should consult with a healthcare provider or a genetic counselor to understand its benefits and limitations in the context of their personal health history and family background.
The CHGB Gene Amyotrophic Lateral Sclerosis Risk Factor Genetic Test is a specialized diagnostic tool designed to assess an individual's genetic predisposition to Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. This test specifically focuses on mutations in the CHGB gene, which have been associated with an increased risk of developing ALS. Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, this test offers a comprehensive evaluation for individuals concerned about their genetic risk for ALS. The test is priced at 4400 AED and provides valuable insights, enabling individuals to make informed decisions about their health and potentially guiding future medical management and lifestyle adjustments in consultation with healthcare professionals.
